help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bilezikjian, L. M.
Right arrow Articles by Vale, W. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bilezikjian, L. M.
Right arrow Articles by Vale, W. W.

Endocrinology, Vol 133, 2545-2553, Copyright © 1993 by Endocrine Society


ARTICLES

Characterization and the regulation of inhibin/activin subunit proteins of cultured rat anterior pituitary cells

LM Bilezikjian, JM Vaughan and WW Vale
Clayton Foundation Laboratories for Peptide Biology, Salk Institute, La Jolla, California 92037.

The production of inhibin/activin by cultured rat anterior pituitary cells was evaluated using specific antisera to inhibin/activin alpha, beta A, and beta B subunit proteins (anti-alpha, anti-beta A, and anti- beta B). Cellular or secreted proteins recognized by the antisera were immunoprecipitated from metabolically labeled cells then analyzed by denaturing polyacrylamide gel electrophoresis. Immunoreactive inhibin/activin beta B proteins were visualized in both cell lysates and the media. Experiments with anti-beta B confirmed that activin-B (beta B beta B) is a local secretory product of cultured rat anterior pituitary cells. The secreted beta B-immunoreactive protein band had an apparent size of 24-25 kilodaltons (kDa) or 14-15 kDa, consistent with the size of unreduced beta B dimer or reduced monomer, respectively. Cell lysates contained two proteins that were specifically immunoprecipitated by anti-beta B. One of these had a mobility of greater than 95 kDa (unreduced) or 55-60 kDa (reduced), probably representing dimers or monomers of the beta B precursor, respectively. The second 14- to 15-kDa (reduced and unreduced) immunoreactive beta B protein band was verified to be the mature beta B monomer. Mature heterodimeric inhibin-B (alpha beta B) was not detected by either anti- alpha or anti-beta B. Multiple protein species, however, were observed to be specifically immunoprecipitated by incubation of cell lysates with anti-alpha. Mature beta A monomer was not detected in any of the samples. The regulation of cellular beta B production was monitored by evaluating its rate of synthesis in pulse-labeled cells. Treatment with either forskolin or 12-O-tetradecanoylphorbol acetate enhanced the rate of [35S]cysteine incorporation into the cellular 14- to 15-kDa beta B monomer, indicating that the activation of either protein kinase A or protein kinase C regulates its production. The rate of cellular beta B accumulation was also regulated by activin-A, inhibin-A, and follistatin; activin-A caused a 30% inhibition in contrast to the 70% stimulation by treatment with either inhibin-A or follistatin. Equimolar concentrations of activin-A and follistatin prevented the net effect produced by either factor alone. None of the immunoreactive alpha-forms was detectable under similar pulse-labeling conditions, and there was no apparent change in their level after labeling to equilibrium (up to 48 h). The observed changes in beta B accumulation may, therefore, reflect the regulated production of pituitary activin- B. Taken together, these results suggest that locally produced activin- B or gonadal activins exert an inhibitory tone on the production of pituitary activin-B and that this negative-feedback control is in turn modulated by inhibins and follistatins. The relative importance of pituitary and gonadal activins, inhibins, and follistatins in the proposed regulatory loop remains to be established.


This article has been cited by other articles:


Home page
Biol. Reprod.Home page
J. P. Moore ,Jr. and S. J. Winters
Weaning and the Developmental Changes in Follicle-Stimulating Hormone, Pituitary Adenylate Cyclase-Activating Polypeptide, and Inhibin B in the Male Rat
Biol Reprod, April 1, 2008; 78(4): 752 - 760.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
J. Yeh and B. Kim
Increasing Blunting of Inhibin Responses to Dynamic Ovarian Challenge Is Associated With Reproductive Aging in the Rat
Reproductive Sciences, January 1, 2007; 14(1): 10 - 19.
[Abstract] [PDF]


Home page
Hum Reprod UpdateHome page
I. E. Messinis
Ovarian feedback, mechanism of action and possible clinical implications
Hum. Reprod. Update, September 1, 2006; 12(5): 557 - 571.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. D. Burkart, A. Mukherjee, E. Sterneck, P. F. Johnson, and K. E. Mayo
Repression of the Inhibin {alpha}-Subunit Gene by the Transcription Factor CCAAT/Enhancer-Binding Protein-{beta}
Endocrinology, April 1, 2005; 146(4): 1909 - 1921.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
S. C. Chapman and T. K. Woodruff
Betaglycan Localization in the Female Rat Pituitary: Implications for the Regulation of Follicle-Stimulating Hormone by Inhibin
Endocrinology, December 1, 2003; 144(12): 5640 - 5649.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
A. Schneyer, A. Schoen, A. Quigg, and Y. Sidis
Differential Binding and Neutralization of Activins A and B by Follistatin and Follistatin Like-3 (FSTL-3/FSRP/FLRG)
Endocrinology, May 1, 2003; 144(5): 1671 - 1674.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. M. Bilezikjian, A. M. O. Leal, A. L. Blount, A. Z. Corrigan, A. V. Turnbull, and W. W. Vale
Rat Anterior Pituitary Folliculostellate Cells Are Targets of Interleukin-1{beta} and a Major Source of Intrapituitary Follistatin
Endocrinology, February 1, 2003; 144(2): 732 - 740.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
C. Welt, Y. Sidis, H. Keutmann, and A. Schneyer
Activins, Inhibins, and Follistatins: From Endocrinology to Signaling. A Paradigm for the New Millennium
Experimental Biology and Medicine, October 1, 2002; 227(9): 724 - 752.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Sidis, D. V. Tortoriello, W. E. Holmes, Y. Pan, H. T. Keutmann, and A. L. Schneyer
Follistatin-Related Protein and Follistatin Differentially Neutralize Endogenous vs. Exogenous Activin
Endocrinology, May 1, 2002; 143(5): 1613 - 1624.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
L. M. Bilezikjian, A. Z. Corrigan, A. L. Blount, Y. Chen, and W. W. Vale
Regulation and Actions of Smad7 in the Modulation of Activin, Inhibin, and Transforming Growth Factor-{{beta}} Signaling in Anterior Pituitary Cells
Endocrinology, March 1, 2001; 142(3): 1065 - 1072.
[Abstract] [Full Text] [PDF]


Home page
Biol. Reprod.Home page
B. L. Bohnsack, M. Szabo, S. M. Kilen, D. H.Y. Tam, and N. B. Schwartz
Follistatin Suppresses Steroid-Enhanced Follicle-Stimulating Hormone Release In Vitro in Rats
Biol Reprod, March 1, 2000; 62(3): 636 - 641.
[Abstract] [Full Text]


Home page
Biol. Reprod.Home page
M. E. Wilson and R. J. Handa
Activin Subunit, Follistatin, and Activin Receptor Gene Expression in the Prepubertal Female Rat Pituitary
Biol Reprod, August 1, 1998; 59(2): 278 - 283.
[Abstract] [Full Text]


Home page
EndocrinologyHome page
M. D. Li, G. J. MacDonald, and J. J. Ford
Breed Differences in Expression of Inhibin/Activin Subunits in Porcine Anterior Pituitary Glands
Endocrinology, February 1, 1997; 138(2): 712 - 718.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1993 by The Endocrine Society